Literature DB >> 32774213

Tackling the Biological Diversity in Early Triple-Negative Breast Cancer.

Mafalda Oliveira1,2, Cristina Saura1,2.   

Abstract

Entities:  

Year:  2020        PMID： 32774213      PMCID： PMC7383273          DOI： 10.1159/000508969

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN： 1661-3791            Impact factor:   2.860


× No keyword cloud information.
  9 in total

1.  Assessment of Molecular Relapse Detection in Early-Stage Breast Cancer.

Authors:  Isaac Garcia-Murillas; Neha Chopra; Iñaki Comino-Méndez; Matthew Beaney; Holly Tovey; Rosalind J Cutts; Claire Swift; Divya Kriplani; Maria Afentakis; Sarah Hrebien; Giselle Walsh-Crestani; Peter Barry; Stephen R D Johnston; Alistair Ring; Judith Bliss; Simon Russell; Abigail Evans; Anthony Skene; Duncan Wheatley; Mitch Dowsett; Ian E Smith; Nicholas C Turner
Journal:  JAMA Oncol       Date:  2019-10-01       Impact factor: 31.777

2.  Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation.

Authors:  Jennifer K Litton; Hope S Rugo; Johannes Ettl; Sara A Hurvitz; Anthony Gonçalves; Kyung-Hun Lee; Louis Fehrenbacher; Rinat Yerushalmi; Lida A Mina; Miguel Martin; Henri Roché; Young-Hyuck Im; Ruben G W Quek; Denka Markova; Iulia C Tudor; Alison L Hannah; Wolfgang Eiermann; Joanne L Blum
Journal:  N Engl J Med       Date:  2018-08-15       Impact factor: 91.245

3.  Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial.

Authors:  Gunter von Minckwitz; Andreas Schneeweiss; Sibylle Loibl; Christoph Salat; Carsten Denkert; Mahdi Rezai; Jens U Blohmer; Christian Jackisch; Stefan Paepke; Bernd Gerber; Dirk M Zahm; Sherko Kümmel; Holger Eidtmann; Peter Klare; Jens Huober; Serban Costa; Hans Tesch; Claus Hanusch; Jörn Hilfrich; Fariba Khandan; Peter A Fasching; Bruno V Sinn; Knut Engels; Keyur Mehta; Valentina Nekljudova; Michael Untch
Journal:  Lancet Oncol       Date:  2014-04-30       Impact factor: 41.316

4.  Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers.

Authors:  Sherene Loi; Damien Drubay; Sylvia Adams; Giancarlo Pruneri; Prudence A Francis; Magali Lacroix-Triki; Heikki Joensuu; Maria Vittoria Dieci; Sunil Badve; Sandra Demaria; Robert Gray; Elisabetta Munzone; Jerome Lemonnier; Christos Sotiriou; Martine J Piccart; Pirkko-Liisa Kellokumpu-Lehtinen; Andrea Vingiani; Kathryn Gray; Fabrice Andre; Carsten Denkert; Roberto Salgado; Stefan Michiels
Journal:  J Clin Oncol       Date:  2019-01-16       Impact factor: 44.544

5.  Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy.

Authors:  Norikazu Masuda; Soo-Jung Lee; Shoichiro Ohtani; Young-Hyuck Im; Eun-Sook Lee; Isao Yokota; Katsumasa Kuroi; Seock-Ah Im; Byeong-Woo Park; Sung-Bae Kim; Yasuhiro Yanagita; Shinji Ohno; Shintaro Takao; Kenjiro Aogi; Hiroji Iwata; Joon Jeong; Aeree Kim; Kyong-Hwa Park; Hironobu Sasano; Yasuo Ohashi; Masakazu Toi
Journal:  N Engl J Med       Date:  2017-06-01       Impact factor: 91.245

Review 6.  Triple negative breast cancers: clinical and prognostic implications.

Authors:  S J Dawson; E Provenzano; C Caldas
Journal:  Eur J Cancer       Date:  2009-09       Impact factor: 9.162

7.  Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (Alliance).

Authors:  William M Sikov; Donald A Berry; Charles M Perou; Baljit Singh; Constance T Cirrincione; Sara M Tolaney; Charles S Kuzma; Timothy J Pluard; George Somlo; Elisa R Port; Mehra Golshan; Jennifer R Bellon; Deborah Collyar; Olwen M Hahn; Lisa A Carey; Clifford A Hudis; Eric P Winer
Journal:  J Clin Oncol       Date:  2014-08-04       Impact factor: 44.544

8.  Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer.

Authors:  Peter Schmid; Sylvia Adams; Hope S Rugo; Andreas Schneeweiss; Carlos H Barrios; Hiroji Iwata; Véronique Diéras; Roberto Hegg; Seock-Ah Im; Gail Shaw Wright; Volkmar Henschel; Luciana Molinero; Stephen Y Chui; Roel Funke; Amreen Husain; Eric P Winer; Sherene Loi; Leisha A Emens
Journal:  N Engl J Med       Date:  2018-10-20       Impact factor: 91.245

9.  Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation.

Authors:  Mark Robson; Seock-Ah Im; Elżbieta Senkus; Binghe Xu; Susan M Domchek; Norikazu Masuda; Suzette Delaloge; Wei Li; Nadine Tung; Anne Armstrong; Wenting Wu; Carsten Goessl; Sarah Runswick; Pierfranco Conte
Journal:  N Engl J Med       Date:  2017-06-04       Impact factor: 91.245
  9 in total
  1 in total

1.  Single-Molecule Sensor for High-Confidence Detection of miRNA.

Authors:  Kalani M Wijesinghe; Mazhar A Kanak; J Chuck Harrell; Soma Dhakal
Journal:  ACS Sens       Date:  2022-03-21       Impact factor: 7.711
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.